Gut microbiota diversity repeatedly diminishes over time following maintenance infliximab infusions in paediatric IBD patients.
<h4>Background</h4>The gut microbiome plays a crucial role in the pathogenesis and progression of inflammatory bowel disease (IBD). Understanding the dynamics of the gut microbiome in relation to treatment can provide valuable insights into disease management and therapy strategies. The...
Saved in:
| Main Authors: | Katrine Carlsen, Louise B Thingholm, Astrid Dempfle, Mikkel Malham, Corinna Bang, Andre Franke, Vibeke Wewer |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2024-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0311604 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Safety of Infliximab Infusions in the Community Setting
by: James Ducharme, et al.
Published: (2010-01-01) -
Psoriasiform paradojic reaction associated with infliximab infusion
by: Lorena De Agustín Sierra
Published: (2017-07-01) -
Infusion Reactions to Infliximab in Pediatric Patients with Inflammatory Bowel Disease
by: Rajmohan Dharmaraj, et al.
Published: (2024-11-01) -
Highlights in IBD Epidemiology and Its Natural History in the Paediatric Age
by: Marco Gasparetto, et al.
Published: (2013-01-01) -
Influence of Genetics, Immunity and the Microbiome on the Prognosis of Inflammatory Bowel Disease (IBD Prognosis Study): the protocol for a Copenhagen IBD Inception Cohort Study
by: Johan Burisch, et al.
Published: (2022-06-01)